Soumitra Roy

Soumitra Roy brings to Ensoma more than 25 years of experience in vector development for gene therapy, both in academia and in industry. Prior to Ensoma, he worked on adenoviral and adeno-associated virus (AAV) vector development at the gene therapy program at the University of Pennsylvania and at Johnson & Johnson (Janssen Vaccines), greatly expanding the repertoire of available adenoviral vector serotypes, as well as designing capsid mutants.